Citadel Advisors
NRC icon

Citadel Advisors’s NRC Health Common Stock NRC Stock Holding History

Citadel Advisors’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,200
Closed -$229K – 13813
2025
Q4 		$229K Buy
+12,200
New +$184K ﹤0.01% 10740
2025
Q2 		– Sell
-400
Closed -$5.12K – 14242
2025
Q1 		$5.12K Sell
400
-200
-33% -$3.21K ﹤0.01% 13840
2024
Q4 		$10.6K Buy
600
+300
+100% +$5.69K ﹤0.01% 13596
2024
Q3 		$6.86K Buy
300
+100
+50% +$2.26K ﹤0.01% 13394
2024
Q2 		$4.59K Buy
+200
New +$6.17K ﹤0.01% 13466
2023
Q1 		– Sell
-400
Closed -$14.9K – 15234
2022
Q4 		$14.9K Buy
+400
New +$15.5K ﹤0.01% 13364

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Citadel Advisors's NRC Position: Q1 2026 in Review

Citadel Advisors sold out of NRC Health Common Stock (NRC) in Q1 2026, closing a stake of 10,971 shares — an estimated $206K sold.

Citadel Advisors first reported a position in NRC in Q1 2016 and held it in 28 quarters. The position peaked at $3.04M in Q2 2024. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Citadel Advisors reported no remaining NRC Health Common Stock position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 10,971 NRC Health Common Stock shares in Q1 2026, an estimated $206K.
  • Citadel Advisors first reported a position in NRC Health Common Stock in Q1 2016 and held it in 28 quarters.
  • Citadel Advisors's NRC Health Common Stock position peaked at $3.04M in Q2 2024.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.